SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported earnings of $17.3 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had profit of 88 cents.
The drug developer posted revenue of $78.7 million in the period.
Rigel expects full-year revenue in the range of $285 million to $295 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
